Latest Partnerships News

Toubani Resources has appointed Ausenco as the EPCM contractor for its Kobada Gold Project in Mali, marking a pivotal step toward project execution and a Final Investment Decision.

Patrys Limited has raised $1.77 million through a fully underwritten entitlement offer to fund preclinical studies and business development for its deoxymab therapeutic antibodies. The company also completed a capital consolidation and held a successful AGM, signaling a strategic pivot into immunology and inflammation.

Firebrick Pharma is set to expand its Nasodine product line with the launch of a new throat spray, targeting export markets starting November 2025, beginning with Singapore.

Magnetite Mines has made significant strides in developing its Razorback Iron Ore Project, securing $3.86 million in new funding and uncovering promising rare earth mineralisation at Ironback Hill. The company continues to navigate strategic partnerships and regulatory approvals to advance its long-life magnetite project.

CONNEQT Health reports robust 50% quarter-on-quarter growth in Pulse device sales and launches a new pricing strategy to boost recurring revenue. The company also secures a significant US clinical trial contract and advances cost-cutting efforts.

D3 Energy has secured formal acceptance of its Production Right Application for the ER315 permit in South Africa, marking a pivotal step toward production. The company also broadened its portfolio with new helium and hydrogen permits in Australia and began trading on the US OTCQX market.

Synertec Corporation has reported its strongest first quarter since FY19, driven by a 13% revenue increase and a new order for its Powerhouse microgrid units from Santos. The company’s engineering division also shows promising expansion with a robust project pipeline.

OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.

Astron Limited has achieved major milestones for its Donald Rare Earth and Mineral Sands Project, including government recognition and conditional financing, setting the stage for a Final Investment Decision by year-end.

Terragen Holdings expands its probiotic product range into beef and lamb feedlots, secures key international approvals, and progresses large-scale trials while maintaining a $3 million cash reserve.

L1 Group has successfully completed a $286 million institutional placement and a $19 million share sale, positioning itself for accelerated growth and strategic expansion. A follow-up share purchase plan aims to raise an additional $25 million from existing shareholders.

Camplify Holdings has locked in a $3.21 million strategic investment from JB Group, which will take a 12.7% stake and partner to accelerate growth through dealership integration and marketing.